Skip to content
Medical Health Aged Care

EW Healthcare Partners Acquires Stake in Boiron Group, a Leader in Natural Medicine

EW Healthcare Partners 2 mins read

LONDON, UK / ACCESSWIRE / October 27, 2023 / EW Healthcare Partners announced that it has acquired a c. 25% minority stake in Boiron Developpement, an entity formed for the purposes of launching a tender offer for the Boiron Group, in partnership with the Boiron Family, at a c. €875 million enterprise value. As part of this transaction, the Boiron family has transferred its 70% stake in the Boiron Group to Boiron Developpement, together with the Boiron employee fund for c. 5% of the capital.

Boiron is a French pharmaceutical company focused on natural medicine, founded in 1932 by pharmacists Jean and Henri Boiron. The company is built around homeopathy and has spearheaded the industry's global development.

Boiron today is the global market leader in homeopathy and a leading global player in natural medicines, with 2022 revenues of €534M. The company offers a diversified portfolio of natural, innovative, science-based, and personalized pharmaceutical products. Over 50% of Boiron's sales are realized outside of France. Boiron benefits from an integrated value chain from registration to distribution, including in-house manufacturing, with the company currently present in 50 countries globally through 23 subsidiaries and 30 distributors. Boiron has also established a strong footprint in the U.S. with €120M in U.S. revenue, with a large portion of products sold through the e-commerce channel.

EW Healthcare Partners is excited to partner with the Boiron family to help further accelerate the company's growth, by expanding the company's offering into additional healthcare verticals and capitalising on the existing platform to launch additional products, in particular in the U.S.

About EW Healthcare Partners ("EW")

With over $2 billion of capital raised since 2014, EW Healthcare Partners seeks to make growth equity investments in fast-growing commercial-stage healthcare companies in the pharmaceutical, medical device, diagnostics, and technology-enabled services sectors in the United States and in Europe. EW Healthcare Partners has a singular commitment to the healthcare industry and has been a long-term investor in numerous healthcare companies, ranging across sectors, stages and geographies. The team of senior investment professionals, operating partners and advisors is based in New York, London and Houston. https://www.ewhealthcare.com

Contact Information

Anne DeMaret
Investor Relations
ademaret@ewhealthcare.com
(281) 528-1956

SOURCE: EW Healthcare Partners

.


View source version on accesswire.com:
https://www.accesswire.com/797118/ew-healthcare-partners-acquires-stake-in-boiron-group-a-leader-in-natural-medicine

More from this category

  • Medical Health Aged Care
  • 26/06/2024
  • 06:02
Omico

National Press Club Address ‘No time to waste, no more lives to lose’ says genomics pioneer. A bold and innovative approach is needed to fight cancer

26 June 2024: With one Australian dying from cancer every ten minutes and up to a third of these from rare cancers,1 Professor David Thomas, Chief Science and Strategy Officer at not-for-profit Genomics Organisation, Omico, and Director, Centre of Molecular Oncology, UNSW is making an urgent plea for Australia to utilise new transformative technologies now in our hands to extend and save the lives of those fighting the toughest cancers. Addressing the National Press Club on Rare Cancers Awareness Day (26 June), Prof Thomas will call for a bolder approach to harnessing rapid advances in cancer innovation known as ‘precision…

  • Medical Health Aged Care
  • 26/06/2024
  • 06:01
Omico

‘No more time to waste and no more lives to lose’ National Press Club Address for Rare Cancers Awareness Day

PHOTO/FILMING/INTERVIEW OPPORTUNITY Date: Wednesday 26 June 2024 Time: 10.30 - 11.30am Venue: National Press Club This Wednesday 26 June,Professor David Thomas, Chief Science and Strategy Officer, at not-for-profit Genomics Organisation, Omico, will make an urgent plea through a National Press Club address for Australia to utilise the new transformative genomic technologies now in our hands to extend and save the lives of those fighting the toughest cancers. With one Australian dying from cancer every ten minutes and up to a third of these from rare cancers,1 he will call for a bolder approach to harnessing rapid advances in cancer innovation…

  • Medical Health Aged Care
  • 26/06/2024
  • 05:00
The Australian Primary Health Care Nurses Association (APNA)

2 in 5 Primary Health Care Nurses at risk of leaving Primary Health Care

The Australian Primary Health Care Nurses Association (APNA) will meet with Members of Parliament in Canberra this week to discuss solutions and help fix a range of workforce issues which have the potential to cause an exodus of nurses from the country’s primary health care sector in the next five years. The annual APNA National Workforce Survey found that 37% of primary health care nurses and midwives are at risk of leaving primary health care in the next two to five years. APNA Chief Executive Officer, Ken Griffin, said: “We’re obviously extremely concerned that only 2in5of the current workforce say…

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.